Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

Innovid Corp. (CTV) Stock Forecast 2025 - AI Price Prediction & Analysis

Innovid Corp. (CTV) AI Stock Price Forecast & Investment Analysis

Innovid Corp. Stock Price Chart and Technical Analysis

Loading Innovid Corp. interactive price chart and technical analysis...

Innovid Corp. (CTV) - Comprehensive Stock Analysis & Investment Research

Deep dive into Innovid Corp.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about Innovid Corp., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For Innovid Corp.: Innovid Corp. operates in the Technology sector, making it an emerging small-cap investment.

Innovid Corp. (Stock Symbol: CTV) is a leading company in the Technology sector , specifically operating within the Services-Prepackaged Software industry.

The organization employs approximately 531 professionals worldwide .

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing Innovid Corp.'s revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Innovid Corp.: With $29M in annual revenue and -72.6% net margin, the company demonstrates developing profitability.

Annual Revenue: $29 million generating a -72.6% net profit margin .

Market Capitalization: $466 million - Classified as a small-cap investment offering high growth potential.

Return on Equity (ROE): -34.7% - Below-average shareholder return efficiency, indicating areas for operational improvement.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for Innovid Corp. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Spearman correlation coefficient shows the statistical relationship between predictions and actual outcomes.

For Innovid Corp.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Innovid Corp. stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: Innovid Corp.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For Innovid Corp.: Market positioning analysis based on available financial and operational metrics.

Innovid Corp. strategically competes in the highly dynamic Services-Prepackaged Software marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

The company maintains a healthy 55.9% gross margin, indicating strong pricing power and operational efficiency.

Innovid Corp. (CTV) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for Innovid Corp. stock analysis.

Loading Innovid Corp. comprehensive fundamental analysis and insider trading data...

Deep dive into Innovid Corp.'s financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if Innovid Corp. stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For Innovid Corp.: With a P/E ratio of -21.59, the market sees the stock as potentially undervalued.

P/E Ratio -21.59x
P/B Ratio 2.34x
Market Cap $466M
EPS $0.03
Book Value/Share $1.35
Revenue/Share $0.39
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently Innovid Corp. converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For Innovid Corp.: An ROE of -34.7% indicates room for improvement in shareholder value creation.

ROE -34.7%
ROA -27.2%
ROIC -32.9%
Gross Margin 55.9%
Operating Margin -3.0%
Net Margin -72.6%
EBT Margin -16.3%
Tax Rate 20.8%
Understanding Financial Health Metrics

What these metrics mean: These ratios assess Innovid Corp.'s ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For Innovid Corp.: A current ratio of 3.52 indicates strong liquidity.

Current Ratio 3.52x
Quick Ratio 3.26x
D/E Ratio 0.02x
Financial Leverage 1.27x
Interest Coverage -1.3x
Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal Innovid Corp.'s ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For Innovid Corp.: Free cash flow of $-20M indicates cash challenges that need attention.

Operating Cash Flow $-15M
Free Cash Flow $-20M
Capital Spending $-5M
FCF/Sales -19.9%
CapEx/Sales 4.8%
Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively Innovid Corp. uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For Innovid Corp.: An asset turnover of 0.38x suggests room for improvement in asset utilization.

Asset Turnover 0.38x
Receivables Turnover 2.5x
Fixed Assets Turnover 9.7x
Days Sales Outstanding 144 days
Payables Period 68 days
Understanding Financial Statement Data

What these metrics mean: Key figures from Innovid Corp.'s income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For Innovid Corp.: With annual revenue of $29M, Innovid Corp. represents a smaller but potentially high-growth operation.

Income Statement ($ Millions)
Total Revenue $29M
Operating Income $15M
Net Income $1M
R&D Expense $2M
SG&A Expense $68M
Cost of Goods Sold $6M
Balance Sheet Highlights (% Of Assets)
Total Current Assets 35%
Cash & Short-term Investments 18%
Total Liabilities 22%
Short-term Debt 2%
Accounts Receivable 15%
Dividend & Shareholder Information
Shares Outstanding 148M
Growth Metrics (YoY)
EPS Growth 1.0%

Latest Innovid Corp. Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting Innovid Corp. (CTV) stock price and investment outlook.

, source: Seeking Alpha

Thank you, operator. Before we begin, I'll remind you that today's call may contain forward-looking statements and that the safe harbor statement in today's earnings release available on our Investor ...

, source: Business Insider

(RTTNews) - Innovid Corp. (CTV) reported Loss for second quarter that decreased from the same period last year but missed the Street estimates. The company's bottom line totaled -$10.542 million, or ...

, source: Business Insider

Innovid Inc. ( (CTV)) has released its Q3 earnings. Here is a breakdown of the information Innovid Inc. presented to its investors. Innovid Corp. is an independent software platform headquartered in ...

, source: ETF Daily News

Innovid Corp. (NYSE:CTV – Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest totalling 1,100,000 shares, an increase of ...

Innovid Corp. Competitors & Peer Analysis - Technology Sector

Comparative analysis of Innovid Corp. against industry peers and competitors in the Technology sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ACIW Unlock Forecast - 30 Days FREE Trial $4741M 18.2x 3.2x
ADBE Unlock Forecast - 30 Days FREE Trial $145429M 20.9x 12.4x
AEYE Unlock Forecast - 30 Days FREE Trial $163M -61.5x 28.8x
AI Unlock Forecast - 30 Days FREE Trial $2074M -16.8x 2.6x
AIFF Unlock Forecast - 30 Days FREE Trial $23M -4.2x 2.4x
AISP Unlock Forecast - 30 Days FREE Trial $118M x -7.3x
ALKT Unlock Forecast - 30 Days FREE Trial $2233M -75.9x 6.4x
ALRM Unlock Forecast - 30 Days FREE Trial $2584M 20.3x 3.1x
ALSAF Unlock Forecast - 30 Days FREE Trial $40M x x
ALSUF Unlock Forecast - 30 Days FREE Trial $6M x x
AMPL Unlock Forecast - 30 Days FREE Trial $1444M -16.9x 5.5x
AMST Unlock Forecast - 30 Days FREE Trial $11M -2.6x 5.0x
APCX Unlock Forecast - 30 Days FREE Trial $16M -0.8x 11.0x
API Unlock Forecast - 30 Days FREE Trial $1567M x 2.4x
APPF Unlock Forecast - 30 Days FREE Trial $8561M 42.0x 17.2x
APPN Unlock Forecast - 30 Days FREE Trial $2907M -27.3x -56.8x
ASAN Unlock Forecast - 30 Days FREE Trial $3346M -12.4x 17.8x
ASFT Unlock Forecast - 30 Days FREE Trial $1M x x
ATDS Unlock Forecast - 30 Days FREE Trial $0M x x
ATHR Unlock Forecast - 30 Days FREE Trial $73M x 12.4x
AVDX Unlock Forecast - 30 Days FREE Trial $2077M 1104.8x 3.0x
AVPT Unlock Forecast - 30 Days FREE Trial $2804M 1423.4x 6.0x
AWRE Unlock Forecast - 30 Days FREE Trial $46M -8.1x 1.7x
BAND Unlock Forecast - 30 Days FREE Trial $435M -30.3x 1.1x
BASE Unlock Forecast - 30 Days FREE Trial $1354M -10.2x 10.9x
BB Unlock Forecast - 30 Days FREE Trial $2509M -11.9x 3.5x
BBAI Unlock Forecast - 30 Days FREE Trial $3059M -3.9x 5.0x
BILL Unlock Forecast - 30 Days FREE Trial $5448M -533.4x 1.4x
BKYI Unlock Forecast - 30 Days FREE Trial $6M -26.8x 1.0x
BL Unlock Forecast - 30 Days FREE Trial $3476M 45.7x 10.6x
BLIN Unlock Forecast - 30 Days FREE Trial $11M -2.4x 1.1x
BLKB Unlock Forecast - 30 Days FREE Trial $3026M 88.2x 28.0x
BMR Unlock Forecast - 30 Days FREE Trial $34M x 1.9x
BNZI Unlock Forecast - 30 Days FREE Trial $7M x 1.3x
BOX Unlock Forecast - 30 Days FREE Trial $4559M 34.3x -16.8x
BRZE Unlock Forecast - 30 Days FREE Trial $3208M -36.2x 5.4x
BSQKZ Unlock Forecast - 30 Days FREE Trial $49445M 16.5x 2.2x
BSY Unlock Forecast - 30 Days FREE Trial $14392M 53.4x 12.0x
CANG Unlock Forecast - 30 Days FREE Trial $285M x 0.1x
CBDW Unlock Forecast - 30 Days FREE Trial $0M x x
CCCS Unlock Forecast - 30 Days FREE Trial $4828M 396.6x 2.3x
CCLD Unlock Forecast - 30 Days FREE Trial $131M 12.2x 2.3x
CCLDO Unlock Forecast - 30 Days FREE Trial $1078M 79.7x 18.6x
CCRD Unlock Forecast - 30 Days FREE Trial $184M 76.0x 3.3x
CCSI Unlock Forecast - 30 Days FREE Trial $425M 5.2x -8.3x
CDNS Unlock Forecast - 30 Days FREE Trial $92294M 87.0x 17.8x
CERT Unlock Forecast - 30 Days FREE Trial $1525M 140.2x 1.4x
CFLT Unlock Forecast - 30 Days FREE Trial $7893M -15.7x 7.1x
CGNT Unlock Forecast - 30 Days FREE Trial $621M x 3.1x
CHKP Unlock Forecast - 30 Days FREE Trial $20726M x 6.7x
CLBT Unlock Forecast - 30 Days FREE Trial $4469M x 10.9x
CLOQ Unlock Forecast - 30 Days FREE Trial $24M x x
CLPS Unlock Forecast - 30 Days FREE Trial $12M x 0.7x
COUR Unlock Forecast - 30 Days FREE Trial $1391M -14.2x 2.2x
CRM Unlock Forecast - 30 Days FREE Trial $250668M 34.7x 4.2x
CRNC Unlock Forecast - 30 Days FREE Trial $563M -0.5x 3.7x
CRWD Unlock Forecast - 30 Days FREE Trial $127959M 4606.3x 31.9x
CRWV Unlock Forecast - 30 Days FREE Trial $36395M x 9.4x
CVLT Unlock Forecast - 30 Days FREE Trial $5330M 66.4x 25.3x
CWAN Unlock Forecast - 30 Days FREE Trial $5764M 14.7x 2.9x
CXM Unlock Forecast - 30 Days FREE Trial $2056M 18.3x 3.7x
CYBR Unlock Forecast - 30 Days FREE Trial $23661M x 10.0x
CYCA Unlock Forecast - 30 Days FREE Trial $7M x x
DAY Unlock Forecast - 30 Days FREE Trial $11051M 223.4x 4.1x
DBX Unlock Forecast - 30 Days FREE Trial $8189M 16.3x 0.0x
DDD Unlock Forecast - 30 Days FREE Trial $397M 25.3x 1.8x
DDOG Unlock Forecast - 30 Days FREE Trial $54796M 513.2x 15.9x
DH Unlock Forecast - 30 Days FREE Trial $267M -1.3x 0.9x
DOCU Unlock Forecast - 30 Days FREE Trial $13154M 43.5x 6.6x
DOMO Unlock Forecast - 30 Days FREE Trial $352M -3.7x 0.0x
DPLS Unlock Forecast - 30 Days FREE Trial $2M x x
DRTTF Unlock Forecast - 30 Days FREE Trial $144M 32.8x 4.6x
DSGX Unlock Forecast - 30 Days FREE Trial $7970M x 5.3x
DSNY Unlock Forecast - 30 Days FREE Trial $5M x 1.9x
DT Unlock Forecast - 30 Days FREE Trial $13415M 26.5x 4.8x
DTSS Unlock Forecast - 30 Days FREE Trial $11M -6.8x 3.5x
DUOL Unlock Forecast - 30 Days FREE Trial $9741M 25.2x 7.5x
DUOT Unlock Forecast - 30 Days FREE Trial $205M -2.8x 4.1x
EA Unlock Forecast - 30 Days FREE Trial $50776M 57.4x 8.5x
EBZT Unlock Forecast - 30 Days FREE Trial $4M x 6.6x
EGAN Unlock Forecast - 30 Days FREE Trial $271M 7.9x 3.3x
ELRA Unlock Forecast - 30 Days FREE Trial $1M x x
ESTC Unlock Forecast - 30 Days FREE Trial $7936M 11163.5x 8.9x
EVCM Unlock Forecast - 30 Days FREE Trial $1745M -59.0x 2.4x
EXFY Unlock Forecast - 30 Days FREE Trial $143M -12.3x 1.1x
FALC Unlock Forecast - 30 Days FREE Trial $11M x x
FATN Unlock Forecast - 30 Days FREE Trial $39M x 1.9x
FCUL Unlock Forecast - 30 Days FREE Trial $8M x 174.7x
FDCT Unlock Forecast - 30 Days FREE Trial $30M x 1.8x
FNGR Unlock Forecast - 30 Days FREE Trial $80M -16.8x 5.3x
FROG Unlock Forecast - 30 Days FREE Trial $7663M -60.2x 8.9x
FRSH Unlock Forecast - 30 Days FREE Trial $3703M -49.0x 4.4x
FRSX Unlock Forecast - 30 Days FREE Trial $1545M x 260.6x
FRZT Unlock Forecast - 30 Days FREE Trial $2M x x
FSLY Unlock Forecast - 30 Days FREE Trial $1679M -8.6x 1.8x
GDYN Unlock Forecast - 30 Days FREE Trial $812M 86.8x 1.5x
GEG Unlock Forecast - 30 Days FREE Trial $83M 5.1x 1.1x
GEGGL Unlock Forecast - 30 Days FREE Trial $789M 50.1x 10.7x
GHST Unlock Forecast - 30 Days FREE Trial $5M x x
GLBE Unlock Forecast - 30 Days FREE Trial $6877M x 7.7x
GMER Unlock Forecast - 30 Days FREE Trial $1M x x
GMGI Unlock Forecast - 30 Days FREE Trial $102M -247.8x 0.8x
GTIC Unlock Forecast - 30 Days FREE Trial $0M 0.1x x
GTLB Unlock Forecast - 30 Days FREE Trial $6199M 654.1x 6.7x
GTM Unlock Forecast - 30 Days FREE Trial $3119M 30.0x 2.0x
GWRE Unlock Forecast - 30 Days FREE Trial $18202M 197.9x 11.9x
GXAI Unlock Forecast - 30 Days FREE Trial $9M -1.3x 0.7x
HPAI Unlock Forecast - 30 Days FREE Trial $143M x 8.8x
HUBS Unlock Forecast - 30 Days FREE Trial $19835M -5033.1x 10.7x
IDAI Unlock Forecast - 30 Days FREE Trial $17M -0.7x 2.7x
IFBD Unlock Forecast - 30 Days FREE Trial $8M x 0.1x
INFA Unlock Forecast - 30 Days FREE Trial $7698M 3931.5x 3.1x
INLX Unlock Forecast - 30 Days FREE Trial $39M 1318.3x 3.4x
INSE Unlock Forecast - 30 Days FREE Trial $236M 4.3x -116.0x
INTA Unlock Forecast - 30 Days FREE Trial $3529M -173.7x 7.3x
INTU Unlock Forecast - 30 Days FREE Trial $189290M 46.0x 9.8x
ITOX Unlock Forecast - 30 Days FREE Trial $0M x x
IVDA Unlock Forecast - 30 Days FREE Trial $5M -7.5x 0.9x
JAMF Unlock Forecast - 30 Days FREE Trial $1724M -22.8x 2.2x
KC Unlock Forecast - 30 Days FREE Trial $42759M x 4.5x
KLTR Unlock Forecast - 30 Days FREE Trial $255M 17.7x 14.4x
KVYO Unlock Forecast - 30 Days FREE Trial $8458M -19.1x 7.4x
LAW Unlock Forecast - 30 Days FREE Trial $470M -12.7x 3.6x
LFLY Unlock Forecast - 30 Days FREE Trial $112M -0.3x -4.0x
LPSN Unlock Forecast - 30 Days FREE Trial $51M -0.5x -1.2x
MANH Unlock Forecast - 30 Days FREE Trial $10827M 50.1x 35.0x
MAPS Unlock Forecast - 30 Days FREE Trial $91M -10.7x 1.9x
MBLY Unlock Forecast - 30 Days FREE Trial $9512M -9.4x 0.8x
MDB Unlock Forecast - 30 Days FREE Trial $33326M -85.8x 11.5x
MFON Unlock Forecast - 30 Days FREE Trial $17M x x
MGIC Unlock Forecast - 30 Days FREE Trial $1117M x 5.3x
MKTW Unlock Forecast - 30 Days FREE Trial $39M 6.0x 0.0x
MLNK Unlock Forecast - 30 Days FREE Trial $1485M -46.1x 3.8x
MNDY Unlock Forecast - 30 Days FREE Trial $8090M x 6.8x
MQ Unlock Forecast - 30 Days FREE Trial $2229M 51.0x 2.7x
MSFT Unlock Forecast - 30 Days FREE Trial $3591811M 34.2x 9.9x
MSGM Unlock Forecast - 30 Days FREE Trial $12M -0.7x 2.1x
MTBLY Unlock Forecast - 30 Days FREE Trial $2427M x 51.7x
MTC Unlock Forecast - 30 Days FREE Trial $69M x x
MYPS Unlock Forecast - 30 Days FREE Trial $81M -24.1x 0.3x
MYPSW Unlock Forecast - 30 Days FREE Trial $2M -0.4x 0.0x
MYSZ Unlock Forecast - 30 Days FREE Trial $4M -0.3x 0.5x
NABL Unlock Forecast - 30 Days FREE Trial $1387M 534.1x 1.7x
NCNO Unlock Forecast - 30 Days FREE Trial $2786M -119.0x 2.7x
NCSYF Unlock Forecast - 30 Days FREE Trial $6455M x 1.8x
NET Unlock Forecast - 30 Days FREE Trial $69834M -419.2x 51.8x
NICE Unlock Forecast - 30 Days FREE Trial $6717M x 1.9x
NOW Unlock Forecast - 30 Days FREE Trial $177334M 102.5x 15.7x
NTNX Unlock Forecast - 30 Days FREE Trial $14M 0.2x -21.5x
NTWK Unlock Forecast - 30 Days FREE Trial $36M 32.6x 1.0x
NUGN Unlock Forecast - 30 Days FREE Trial $2M x 0.1x
NXNT Unlock Forecast - 30 Days FREE Trial $8M x x
OKTA Unlock Forecast - 30 Days FREE Trial $15408M 79.0x 2.2x
ONTF Unlock Forecast - 30 Days FREE Trial $254M -6.7x 1.8x
OS Unlock Forecast - 30 Days FREE Trial $3M x 0.0x
PATH Unlock Forecast - 30 Days FREE Trial $10123M 501.9x 6.1x
PAYC Unlock Forecast - 30 Days FREE Trial $9164M 20.2x 5.4x
PCOR Unlock Forecast - 30 Days FREE Trial $11671M -134.0x 9.5x
PCTY Unlock Forecast - 30 Days FREE Trial $7967M 35.3x 7.2x
PD Unlock Forecast - 30 Days FREE Trial $1133M 7.3x 3.5x
PDFS Unlock Forecast - 30 Days FREE Trial $1149M 1281.6x 4.4x
PDYN Unlock Forecast - 30 Days FREE Trial $242M -3.0x 4.7x
PDYNW Unlock Forecast - 30 Days FREE Trial $5M 0.0x 0.1x
PLTR Unlock Forecast - 30 Days FREE Trial $433191M 395.5x 65.7x
PNXP Unlock Forecast - 30 Days FREE Trial $0M x 1.6x
PRCH Unlock Forecast - 30 Days FREE Trial $1129M 36.9x -22.8x
PRGS Unlock Forecast - 30 Days FREE Trial $1859M 38.3x 3.9x
PTC Unlock Forecast - 30 Days FREE Trial $20742M 28.3x 5.4x
QLYS Unlock Forecast - 30 Days FREE Trial $5245M 27.7x 9.9x
QTWO Unlock Forecast - 30 Days FREE Trial $4596M 144.8x 7.4x
RBLX Unlock Forecast - 30 Days FREE Trial $67576M -35.7x 165.8x
RBRK Unlock Forecast - 30 Days FREE Trial $16675M x 0.0x
RCAT Unlock Forecast - 30 Days FREE Trial $963M -91.1x 3.8x
RDVT Unlock Forecast - 30 Days FREE Trial $751M 67.1x 7.4x
RPD Unlock Forecast - 30 Days FREE Trial $1058M 56.4x 8.3x
RPMT Unlock Forecast - 30 Days FREE Trial $52M x x
RTCJF Unlock Forecast - 30 Days FREE Trial $23M x 0.9x
S Unlock Forecast - 30 Days FREE Trial $4770M -25.6x 3.1x
SAIL Unlock Forecast - 30 Days FREE Trial $11266M -73.2x 1.7x
SBET Unlock Forecast - 30 Days FREE Trial $2145M x 0.7x
SEMR Unlock Forecast - 30 Days FREE Trial $1754M 169.4x 6.1x
SHOP Unlock Forecast - 30 Days FREE Trial $211019M 432.4x 16.9x
SKIL Unlock Forecast - 30 Days FREE Trial $87M -1.4x 2.0x
SKKY Unlock Forecast - 30 Days FREE Trial $23M x 24.7x
SMSI Unlock Forecast - 30 Days FREE Trial $13M -0.2x 0.7x
SNAL Unlock Forecast - 30 Days FREE Trial $0M -7.0x 0.0x
SNOW Unlock Forecast - 30 Days FREE Trial $76845M -54.7x 36.0x
SNPS Unlock Forecast - 30 Days FREE Trial $86565M 43.3x 3.1x
SPNS Unlock Forecast - 30 Days FREE Trial $2419M x 5.0x
SPSC Unlock Forecast - 30 Days FREE Trial $3156M 37.1x 3.3x
SPT Unlock Forecast - 30 Days FREE Trial $629M -27.5x 3.2x
SSNC Unlock Forecast - 30 Days FREE Trial $21506M 25.2x 3.1x
SSTI Unlock Forecast - 30 Days FREE Trial $79M -38.0x 1.1x
SVCO Unlock Forecast - 30 Days FREE Trial $139M x 1.8x
TAOP Unlock Forecast - 30 Days FREE Trial $15M x 1.0x
TDC Unlock Forecast - 30 Days FREE Trial $2871M 24.3x 13.1x
TEAM Unlock Forecast - 30 Days FREE Trial $41902M -233.9x 30.4x
TENB Unlock Forecast - 30 Days FREE Trial $3182M -81.5x 9.2x
TFLM Unlock Forecast - 30 Days FREE Trial $1M x x
TTAN Unlock Forecast - 30 Days FREE Trial $9614M x 6.5x
TTWO Unlock Forecast - 30 Days FREE Trial $45783M -9.7x 13.3x
TWLO Unlock Forecast - 30 Days FREE Trial $20398M 303.5x 2.6x
TYL Unlock Forecast - 30 Days FREE Trial $22597M 71.7x 6.3x
U Unlock Forecast - 30 Days FREE Trial $19584M -13.5x 6.1x
UMEWF Unlock Forecast - 30 Days FREE Trial $32M x 1.6x
VBIX Unlock Forecast - 30 Days FREE Trial $17M x 3.0x
VEEV Unlock Forecast - 30 Days FREE Trial $39771M 46.2x 5.7x
VPRB Unlock Forecast - 30 Days FREE Trial $4M x x
VRNS Unlock Forecast - 30 Days FREE Trial $3561M -27.4x 5.9x
VWAV Unlock Forecast - 30 Days FREE Trial $24M x x
WBSR Unlock Forecast - 30 Days FREE Trial $12M x x
WEAV Unlock Forecast - 30 Days FREE Trial $504M -36.7x 6.4x
WFCF Unlock Forecast - 30 Days FREE Trial $65M 32.5x 6.3x
WHEN Unlock Forecast - 30 Days FREE Trial $83M x 59.7x
WIMI Unlock Forecast - 30 Days FREE Trial $72M x 0.1x
WK Unlock Forecast - 30 Days FREE Trial $5193M -70.2x 0.0x
XPER Unlock Forecast - 30 Days FREE Trial $276M 39.6x 0.6x
XYZ Unlock Forecast - 30 Days FREE Trial $38209M 12.2x 1.7x
YOU Unlock Forecast - 30 Days FREE Trial $2940M 16.2x 10.1x
ZDGE Unlock Forecast - 30 Days FREE Trial $32M -4.8x 1.2x
ZETA Unlock Forecast - 30 Days FREE Trial $4142M -26.5x 6.0x
ZSPC Unlock Forecast - 30 Days FREE Trial $11M x -3.2x

Frequently Asked Questions - Innovid Corp. Stock Forecast

How accurate are Innovid Corp. stock predictions?

Our AI model shows a 59% Spearman correlation coefficient for CTV predictions, based on advanced machine learning algorithms trained on over 10 years of market data. This measures the strength of the monotonic relationship between predicted and actual price movements.

What factors influence Innovid Corp. stock price forecasts?

Our analysis considers Innovid Corp.'s financial metrics, Technology sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is Innovid Corp. a good investment in 2025?

Based on our AI analysis, Innovid Corp. shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are Innovid Corp. forecasts updated?

Innovid Corp. stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced Innovid Corp. Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for Innovid Corp. stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...